Dexcom's $320M Trading Volume Surges 45% Despite Stock Decline and Massive Recall

On June 18, 2025, Dexcom's trading volume reached $320 million, marking a 45.09% increase from the previous day, ranking 237th in the day's stock market activity. Dexcom's stock price fell by 1.05%, marking the second consecutive day of decline, with a total decrease of 2.45% over the past two days.

Dexcom has issued a recall for its One+, One, G7, and G6 continuous glucose monitors (CGMs) due to potential issues with the receivers for these devices. The recall affects over 2 million CGM receivers, highlighting a significant concern for the company's product safety and reliability.

This recall is part of a broader issue with Dexcom's CGM receivers, which have been identified as a Class I recall. The affected systems include the Dexcom One and One+ offerings, as well as the G6 and G7 CGMs. This recall underscores the importance of addressing product defects promptly to maintain consumer trust and regulatory compliance.